2017年台湾幽门螺杆菌共识:关于幽门螺杆菌感染的临床管理、筛选治疗和监控以改善台湾地区胃癌控制的共识

2018-01-30 胃肠病学和肝病学杂志.2018,27(1):1-12.

既往的国际共识为幽门螺杆菌( Helicobacter pylori,H.pylori) 感染的管理提供了一般性政策。但是,H.pylori 的流行率和抗菌素耐药性、药物和内镜检查的可用性存在地理差异。因此,需要全国或区域性共识来改善H. pylori 感染和胃癌的控制。台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查—治疗和监控。本文强调

中文标题:

2017年台湾幽门螺杆菌共识:关于幽门螺杆菌感染的临床管理、筛选治疗和监控以改善台湾地区胃癌控制的共识

发布机构:

发布日期:

2018-01-30

简要介绍:

既往的国际共识为幽门螺杆菌( Helicobacter pylori,H.pylori) 感染的管理提供了一般性政策。但是,H.pylori 的流行率和抗菌素耐药性、药物和内镜检查的可用性存在地理差异。因此,需要全国或区域性共识来改善H. pylori 感染和胃癌的控制。台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查—治疗和监控。本文强调了关于草案声明发展和证据水平决定的最近数据。共有24 个共识意见。第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证。第二节有10 个推荐声明为一线、二线和三线治疗提供更新的治疗方案。第三节有7 个推荐声明关于根除H.pylori 降低胃癌风险的成本效益分析。根除H.pylori 后,共识突出内镜监控和/或化学预防来进一步减轻胃癌的负担。这一共识声明更新了改善H.pylori感染和胃癌患病率高的台湾地区的H.pylori 感染临床管理的建议。

译者: 南京医科大学附属南京医院( 南京市第一医院) 消化科 李超(译) 张振玉(审)

 

拓展指南:幽门螺杆菌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017年台湾幽门螺杆菌共识:关于幽门螺杆菌感染的临床管理、筛选治疗和监控以改善台湾地区胃癌控制的共识)] GetToolGuiderByIdResponse(projectId=1, id=93bff1c0015626ad, title=2017年台湾幽门螺杆菌共识:关于幽门螺杆菌感染的临床管理、筛选治疗和监控以改善台湾地区胃癌控制的共识, enTitle=, guiderFrom=胃肠病学和肝病学杂志.2018,27(1):1-12., authorId=null, author=, summary=既往的国际共识为幽门螺杆菌( Helicobacter pylori,H.pylori) 感染的管理提供了一般性政策。但是,H.pylori 的流行率和抗菌素耐药性、药物和内镜检查的可用性存在地理差异。因此,需要全国或区域性共识来改善H. pylori 感染和胃癌的控制。台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查—治疗和监控。本文强调, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>既往的国际共识为幽门螺杆菌( Helicobacter pylori,H.pylori) 感染的管理提供了一般性政策。但是,H.pylori 的流行率和抗菌素耐药性、药物和内镜检查的可用性存在地理差异。因此,需要全国或区域性共识来改善H. pylori 感染和胃癌的控制。台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查—治疗和监控。本文强调了关于草案声明发展和证据水平决定的最近数据。共有24 个共识意见。第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证。第二节有10 个推荐声明为一线、二线和三线治疗提供更新的治疗方案。第三节有7 个推荐声明关于根除H.pylori 降低胃癌风险的成本效益分析。根除H.pylori 后,共识突出内镜监控和/或化学预防来进一步减轻胃癌的负担。这一共识声明更新了改善H.pylori感染和胃癌患病率高的台湾地区的H.pylori 感染临床管理的建议。 </P>译者: 南京医科大学附属南京医院( 南京市第一医院) 消化科 李超(译) 张振玉(审) <P> </P>拓展指南:<strong>与<font color=red>幽门螺杆菌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=930e81c001a8057d" title="2017 IHPWG共识:成人幽门螺杆菌感染的诊断和治疗" target=_blank>2017 IHPWG共识:成人幽门螺杆菌感染的诊断和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ccfef1c001a6885b" title="“第五次全国幽门螺杆菌感染处理共识报告”解读" target=_blank>“第五次全国幽门螺杆菌感染处理共识报告”解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=98e421c001a68eda" title="第五次全国幽门螺杆菌感染处理共识报告" target=_blank>第五次全国幽门螺杆菌感染处理共识报告</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=baf381c001a52226" title="【专题】幽门螺杆菌精华指南在手,轻松解决胃病问题" target=_blank>【专题】幽门螺杆菌精华指南在手,轻松解决胃病问题</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d87591c001a52146" title="《幽门螺杆菌感染的处理:Maastricht Ⅴ/Florence共识报告》解读" target=_blank>《幽门螺杆菌感染的处理:Maastricht Ⅴ/Florence共识报告》解读</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%B9%BD%E9%97%A8%E8%9E%BA%E6%9D%86%E8%8F%8C" target=_blank>有关幽门螺杆菌更多指南</a></ul>, tagList=[TagDto(tagId=12528, tagName=幽门螺杆菌感染)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6177, appHits=596, showAppHits=9, pcHits=4414, showPcHits=1826, likes=142, shares=23, comments=9, approvalStatus=1, publishedTime=Thu Mar 01 18:08:41 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 01 18:08:41 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:22:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017年台湾幽门螺杆菌共识:关于幽门螺杆菌感染的临床管理、筛选治疗和监控以改善台湾地区胃癌控制的共识)])
2017年台湾幽门螺杆菌共识:关于幽门螺杆菌感染的临床管理、筛选治疗和监控以改善台湾地区胃癌控制的共识
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=902814, encodeId=d43c9028149b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:00:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292494, encodeId=9f45292494ff, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 03 07:45:11 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292124, encodeId=9cee292124e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:25:55 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292123, encodeId=dcca29212385, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:22:07 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292066, encodeId=f4ea2920660a, content=既往的国际共识为幽门螺杆菌( Helicobacter pylori.H.pylori) 感染的管理提供了一般性政策.但是.H.pylori 的流行率和抗菌素耐药性.药物和内镜检查的可用性存在地理差异.因此.需要全国或区域性共识来改善H. pylori 感染和胃癌的控制.台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查-治疗和监控.本文强调了关于草案声明发展和证据水平决定的最近数据.共有24 个共识意见.第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证.第二节有10 个推荐声明为一线.二线和三线治疗提供更新的治疗方案., beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:18 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2020-11-27 公冶花

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=902814, encodeId=d43c9028149b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:00:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292494, encodeId=9f45292494ff, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 03 07:45:11 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292124, encodeId=9cee292124e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:25:55 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292123, encodeId=dcca29212385, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:22:07 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292066, encodeId=f4ea2920660a, content=既往的国际共识为幽门螺杆菌( Helicobacter pylori.H.pylori) 感染的管理提供了一般性政策.但是.H.pylori 的流行率和抗菌素耐药性.药物和内镜检查的可用性存在地理差异.因此.需要全国或区域性共识来改善H. pylori 感染和胃癌的控制.台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查-治疗和监控.本文强调了关于草案声明发展和证据水平决定的最近数据.共有24 个共识意见.第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证.第二节有10 个推荐声明为一线.二线和三线治疗提供更新的治疗方案., beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:18 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-03 秀红

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=902814, encodeId=d43c9028149b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:00:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292494, encodeId=9f45292494ff, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 03 07:45:11 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292124, encodeId=9cee292124e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:25:55 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292123, encodeId=dcca29212385, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:22:07 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292066, encodeId=f4ea2920660a, content=既往的国际共识为幽门螺杆菌( Helicobacter pylori.H.pylori) 感染的管理提供了一般性政策.但是.H.pylori 的流行率和抗菌素耐药性.药物和内镜检查的可用性存在地理差异.因此.需要全国或区域性共识来改善H. pylori 感染和胃癌的控制.台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查-治疗和监控.本文强调了关于草案声明发展和证据水平决定的最近数据.共有24 个共识意见.第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证.第二节有10 个推荐声明为一线.二线和三线治疗提供更新的治疗方案., beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:18 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-02 121832a9m88暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=902814, encodeId=d43c9028149b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:00:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292494, encodeId=9f45292494ff, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 03 07:45:11 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292124, encodeId=9cee292124e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:25:55 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292123, encodeId=dcca29212385, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:22:07 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292066, encodeId=f4ea2920660a, content=既往的国际共识为幽门螺杆菌( Helicobacter pylori.H.pylori) 感染的管理提供了一般性政策.但是.H.pylori 的流行率和抗菌素耐药性.药物和内镜检查的可用性存在地理差异.因此.需要全国或区域性共识来改善H. pylori 感染和胃癌的控制.台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查-治疗和监控.本文强调了关于草案声明发展和证据水平决定的最近数据.共有24 个共识意见.第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证.第二节有10 个推荐声明为一线.二线和三线治疗提供更新的治疗方案., beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:18 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-02 121832a9m88暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=902814, encodeId=d43c9028149b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Fri Nov 27 15:00:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292494, encodeId=9f45292494ff, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 03 07:45:11 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292124, encodeId=9cee292124e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:25:55 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292123, encodeId=dcca29212385, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Fri Mar 02 03:22:07 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292066, encodeId=f4ea2920660a, content=既往的国际共识为幽门螺杆菌( Helicobacter pylori.H.pylori) 感染的管理提供了一般性政策.但是.H.pylori 的流行率和抗菌素耐药性.药物和内镜检查的可用性存在地理差异.因此.需要全国或区域性共识来改善H. pylori 感染和胃癌的控制.台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查-治疗和监控.本文强调了关于草案声明发展和证据水平决定的最近数据.共有24 个共识意见.第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证.第二节有10 个推荐声明为一线.二线和三线治疗提供更新的治疗方案., beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Mar 01 19:34:18 CST 2018, time=2018-03-01, status=1, ipAttribution=)]
    2018-03-01 有备才能无患

    既往的国际共识为幽门螺杆菌( Helicobacter pylori.H.pylori) 感染的管理提供了一般性政策.但是.H.pylori 的流行率和抗菌素耐药性.药物和内镜检查的可用性存在地理差异.因此.需要全国或区域性共识来改善H. pylori 感染和胃癌的控制.台湾地区H.pylori 管理共识包括三个部分: 最佳的诊断方法和治疗适应证; 当前治疗策略; 胃癌的筛查-治疗和监控.本文强调了关于草案声明发展和证据水平决定的最近数据.共有24 个共识意见.第一节有7 个推荐声明关于H.pylori 感染的诊断和治疗的适应证.第二节有10 个推荐声明为一线.二线和三线治疗提供更新的治疗方案.

    0